Definitive Contract 75N95019C00035
Award Date
8/1/19
Potential Completion Date
9/30/22
Potential Value
$1.3M
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,199,139.00 cost-plus-fixed-fee definitive contract awarded by the Food and Drug Administration (FDA) to The Charles Stark Draper Laboratory, Inc., doing business as Draper. The contract, with a period of performance through March 27, 2023, is for the development of continuous acoustic separation technology for cell therapeutic manufacturing. Draper is a non-profit research and development organization that provides specialized engineering services to the federal government,...
This is a $719,000.00 firm-fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response to The Charles Stark Draper Laboratory, Inc. to develop a high-throughput and immune-competent lung-on-chip with integrated sensing for SARS-CoV-2 analysis. The contract is not set aside for any specific business type. Draper is a not-for-profit research and development organization with expertise in areas such as guidance, navigation, control systems, sensors,...
This is a $749,095 firm fixed-price federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response to The Charles Stark Draper Laboratory, Inc. (doing business as Draper), a not-for-profit research and development organization. The contract, which does not have a set-aside designation, is for the development of a "bioinspired microfluidic oxygenator for long duration ECMO without anticoagulation." Draper has extensive experience as both a prime...
The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, awarded a $60,702,067.00 cost-plus-fixed-fee contract to The Charles Stark Draper Laboratory, Inc. (Draper) to advance the development of a medical countermeasure (MCM) evaluation platform. The platform will consist of vascular-immune and small intestine-immune organ-on-chip models, molecular assays, omics-based technologies, and advanced analytical methods for biomarker...
This is a $2,422,412.00 cost-plus-fixed-fee federal contract awarded by the Defense Threat Reduction Agency (DTRA) to The Charles Stark Draper Laboratory, Inc. (Draper), a non-profit research and development organization. The contract has no set-aside designation. Draper is providing specialized engineering, science, and technical services to support DTRA's critical defense, space, medical, and commercial programs. This includes work on guidance, navigation, control systems, sensors,...
This $1,104,805.00 cost-plus-fixed-fee contract was awarded by the Defense Advanced Research Projects Agency (DARPA) to The Charles Stark Draper Laboratory, Inc. (Draper), a prominent non-profit research and development organization. The contract, which does not have a set-aside designation, is for a DSO (Defense Sciences Office) study focused on supply chain analysis. Draper, which has a strong track record of providing specialized engineering, science, and technical services to various federal...
This is a $85,912.20 firm-fixed-price delivery order issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency within the U.S. Department of Health and Human Services. The order was awarded to Astrix Technology LLC, a for-profit limited liability company, to provide support for multiple data-heavy research projects from over 20 labs across various stages of biomedical research. This includes working with large-scale data from genomic data types such...
This is a $142,686.37 firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Emulate Inc. (doing business as Emulate), a for-profit small business. The contract is for Emulate's human emulation organ-on-a-chip instruments and accessories, which support the National Institute of Neurological Disorders and Stroke's mission to develop in vitro 3D brain organoid models for studying neurological...
This is a $24,872,899.80 Cost Plus Fixed Fee contract awarded by the Department of Homeland Security's Science and Technology Directorate to The Charles Stark Draper Laboratory, Inc. (Draper) for advanced screening research under a larger R&D program. The contract has an ultimate completion date of September 29, 2020. Draper, a non-profit research and development organization, has extensive experience as both a prime contractor and subcontractor on major federal contracts, particularly in...
This is a federal contract award to The Charles Stark Draper Laboratory, Inc. (Draper), a non-profit research and development organization, by the Defense Contract Management Agency. The $2,380,805.00 cost-plus-fixed-fee contract is for risk identification work, with a performance period ending on January 25, 2024. Draper is an experienced prime and subcontractor on major federal programs supporting the Department of the Navy, NASA, and the U.S. Air Force, with expertise across domains like...